5 Biotech Stocks to Sell Now According to Cathie Wood
In this article, we discuss 5 biotech stocks to sell now according to Cathie Wood.
Nanostring Technologies Inc (NSTG)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | 100,901,000 | $110,786 | -7% | 0.02% | |
| 2. | Marshall Wace LLP Paul Marshall And Ian Wace | 1,662,999 | $57,790 | -22% | 0.1% |
| 3. | Polar Capital Brian Ashford-Russell And Tim Woolley | 1,617,733 | $56,216 | +37% | 0.25% |
| 4. | Alyeska Investment Group Anand Parekh | 1,443,432 | $50,159 | +27% | 0.55% |
| 5. | Pura Vida Investments Efrem Kamen | 1,220,332 | $42,407 | +4% | 1.44% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $6.91 | 30,000 | Director | 30,000 | 2018-03-13 | Filing | |
| $6.91 | 30,000 | Director | 30,000 | 2018-03-13 | Filing | |
| $10.00 | 750,000 | Large Shareholder | 3,959,440 | 2013-07-01 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $12.41 | 1,945 | Director | 6,595 | 2022-06-17 | Filing | |
| $27.81 | 8,625 | Officer, Director | 202,298 | 2022-03-15 | Filing | |
| $27.81 | 2,436 | Officer | 85,372 | 2022-03-15 | Filing | |
| $27.81 | 2,110 | Officer | 19,372 | 2022-03-15 | Filing | |
| $33.81 | 5,000 | Officer | 16,105 | 2022-03-10 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value (x$1000) | % Port |
|---|---|---|---|---|
| 1. | 240,761 | $8,366,447 | 0% | |
| 2. | 6,864,161 | $238,530 | 0.01% | |
| 3. | 5,304,475 | $184,329 | 0.03% | |
| 4. | 4,321,660 | $150,177 | 0% | |
| 5. | 3,948 | $137,193 | 0% |
News See All
Hedge Funds Are Piling Into NanoString Technologies Inc (NSTG)
Our extensive research has shown that imitating the smart money can generate significant returns for retail investors, which is why we track nearly 900 active prominent money managers and analyze their...
5 Pharmaceutical Stocks to Buy According to Efrem Kamen's Pura Vida Investments
Below is the list of 5 pharmaceutical stocks to buy according to Efrem Kamen's Pura Vida Investments hedge fund.
Should I Buy NanoString Technologies Inc (NSTG)?
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Cathie Wood's Top 15 Small-Cap Stock Picks
In this article, we discuss Cathie Wood’s top 15 small-cap stock picks.
10 Small-Cap Stocks to Buy According to 'Australia's Warren Buffett' Kerr Neilson
In this article, we discuss the 10 small-cap stocks to buy according to Australian billionaire Kerr Neilson.
Hedge Funds Aren't Crazy About NanoString Technologies Inc (NSTG) Anymore
Many prominent investors, including Warren Buffett, David Tepper and Stan Druckenmiller, have been cautious regarding the current bull market and missed out as the stock market reached another high in...
Is NSTG Stock A Buy or Sell?
The Insider Monkey team has completed processing the quarterly 13F filings for the December quarter submitted by the hedge funds and other money managers included in our extensive database.
Hedge Fund and Insider Trading News: Elliott Management, Brevan Howard Asset Management, IPI Partners, BlackRock Inc., RPM International Inc. (RPM), and More
LONDON (Reuters) -Activist hedge fund Elliott Management has taken a multi-billion pound stake in GlaxoSmithKline, the Financial Times reported on Thursday, after a year that has seen the British pharma...
Is NSTG A Good Stock To Buy Now?
The financial regulations require hedge funds and wealthy investors that exceeded the $100 million equity holdings threshold to file a report that shows their positions at the end of every quarter.
Billionaire Hedge Funds
